The Role of Fluconazole in the Treatment of Candida Endocarditis: A Meta-Analysis
The DOI matches its Crossref record; 90 of the 94 references it cites were found in a registry or an index.
Abstract
The treatment of Candida infective endocarditis generally involves infected valve removal accompanied by antifungal therapy with amphotericin B or a lipid-based derivative, with or without flucytosine. While often used as chronic suppressive therapy in these patients, the precise role for fluconazole has not been established. We conducted a meta-analysis of 64 literature cases of Candida endocarditis whose management did not include valve replacement but who received fluconazole, alone or concurrently or in sequence with 1 or more other antifungal drugs.Forty-nine (77%) patients were cured (n = 44) or improved (n = 5), 4 relapsed (6%), and 11 failed (10 of whom died) (17%). Among 19 patients for whom fluconazole was administered as the sole antifungal therapy, 11 (58%) were cured or improved. In contrast, among 45 patients who received 1 or more other antifungal agents in addition to fluconazole, 38 (84%) were cured or improved (p = 0.02). Eighteen of 21 (86%) patients with native valve infection were cured or improved compared with 13 of 19 (68%) patients with prosthetic valve endocarditis (p = 0.13). The mean duration of successful fluconazole regimens was 134 days. Twenty of 21 (95%) patients who received fluconazole as chronic suppressive therapy for ≥6 months were cured. Prognosis was independent of Candida species or patient age. Among 23 historical controls managed with fluconazole-containing antifungal therapy plus valvular surgery, survival was 91%.In conclusion, flu…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174
Moudgal, V., Little, T., Boikov, D., & Vazquez, J. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.767-769.2005 · Cited by 242 · cited 1×
“In a third patient, relapse at 3 months led to discontinuation of chronic suppressive fluconazole; he later improved and his blood cultures cleared on amphotericin B lipid complex with no further follow-up.(59) The fourth patient failed fluconazole monotherapy and no further follow-up was given.”
BackgroundCandida infective endocarditis
Baddley, J. W., Benjamin, D. K., Patel, M., Miró, J., Athan, E., Barsic, B., Bouza, E., Clara, L., Elliott, T., Kanafani, Z., et al. (2008) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-008-0466-x · Cited by 213
Girmenia, C., Martino, P., De Bernardis, F., Gentile, G., Boccanera, M., Monaco, M., Antonucci, G., & Cassone, A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.506 · Cited by 164
Microbiological aspects ofHelicobacter pylori (Campylobacter pylori)
Goodwin, C. S., & Armstrong, J. A. (1990) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01969526 · Cited by 151
Candida Infective Endocarditis: Report of 15 Cases From a Prospective Multicenter Study
Falcone, M., Barzaghi, N., Carosi, G., Grossi, P., Minoli, L., Ravasio, V., Rizzi, M., Suter, F., Utili, R., Viscoli, C., et al. (2009) · Medicine · doi:10.1097/md.0b013e3181a693f8 · Cited by 138
Infectious Complications in Left Ventricular Assist Device Recipients
Fischer, S. A., Trenholme, G. M., Costanzo, M. R., & Piccione, W. J. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.1.18 · Cited by 123
Candida Prosthetic Valve Endocarditis: Prospective Study of Six Cases and Review of the Literature
Nguyen, M. H., Nguyen, M. L., Vu, V. L., McMahon, D., Keys, T. F., & Amidi, M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.262 · Cited by 109
Melgar, G. R., Nasser, R. M., Gordon, S. M., Lytle, B. W., Keys, T. F., & Longworth, D. L. (1997) · Medicine · doi:10.1097/00005792-199703000-00002 · Cited by 106
Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro
Odds, F. C., Cheesman, S. L., & Abbott, A. B. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.4.473 · Cited by 89
Lye, D. C., Hughes, A. J., O'Brien, D. P., & Athan, E. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0038-2 · Cited by 78
Sanati, H., Ramos, C. F., Bayer, A. S., & Ghannoum, M. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1345 · Cited by 76
Louie, A., Liu, W., Miller, D. A., Sucke, A. C., Liu, Q.-F., Drusano, G. L., Mayers, M., & Miller, M. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2831 · Cited by 72
Pharmacokinetics and tissue penetration of fluconazole in rabbits
Walsh, T. J., Foulds, G., & Pizzo, P. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.4.467 · Cited by 71
Resurgence of Pseudomonas Endocarditis in Detroit, 2006-2008
Reyes, M. P., Ali, A., Mendes, R. E., & Biedenbach, D. J. (2009) · Medicine · doi:10.1097/md.0b013e3181b8bedc · Cited by 69
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
Isalska, B. J., & Stanbridge, T. N. (1988) · BMJ · doi:10.1136/bmj.297.6642.178 · Cited by 65
Presterl, E., Daxböck, F., Graninger, W. B., & Willinger, B. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01812.x · Cited by 63
Louie, A., Kaw, P., Banerjee, P., Liu, W., Chen, G. L., & Miller, M. H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.485-494.2001 · Cited by 55 · cited 1×
“In contrast, other authors have noted that amphotericin B monotherapy or amphotericin B combined with fluconazole significantly decreased fungal densities in cardiac vegetations in experimental Candida endocarditis compared to untreated controls or fluconazole monotherapy.(49,75) Louie et al(49,50) reported that ampho…”
ResultSuccessful Treatment of Fungal Prosthetic Valve Endocarditis: Case Report and Review
Gilbert, H. M., Peters, E. D., Lang, S. J., & Hartman, B. J. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.348 · Cited by 54
López-Ciudad, V., Castro-Orjales, M. J., León, C., Sanz-Rodríguez, C., de la Torre-Fernández, M. J., de Juan-Romero, M. A. P., Collell-Llach, M. D., & Díaz-López, M. D. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-73 · Cited by 52 · cited 1×
“Voriconazole, but not posaconazole, has been used in the treatment of Candida endocarditis, but clinical experience is extremely limited.(48,52,53,67) While fluconazole is commonly used for chronic suppression in patients with Candida endocarditis, to our knowledge its precise role in the management of this infection…”
Late Recurrent Candida Endocarditis
Johnston, P. G., Lee, J., Domunski, M., Dressler, F., Tucker, E., Rothenberg, M., Cunnion, R. E., Pizzo, P. A., & Walsh, T. J. (1991) · Chest · doi:10.1378/chest.99.6.1531 · Cited by 51
Fungal endocarditis: Need for guidelines in evaluating therapy
Galgiani, J. N., & Stevens, D. A. (1977) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39961-1 · Cited by 50
Voriconazole-Induced Photosensitivity
Malani, A. N., & Aronoff, D. M. (2008) · Clinical Medicine & Research · doi:10.3121/cmr.2008.806 · Cited by 49 · cited 1×
“Voriconazole, but not posaconazole, has been used in the treatment of Candida endocarditis, but clinical experience is extremely limited.(48,52,53,67) While fluconazole is commonly used for chronic suppression in patients with Candida endocarditis, to our knowledge its precise role in the management of this infection…”
Prabhu, R. M., & Orenstein, R. (2004) · Clinical Infectious Diseases · doi:10.1086/424449 · Cited by 47
Candida endocarditis in neonates: report of five cases and review of the literature
Levy, I., Shalit, I., Birk, E., Sirota, L., Ashkenazi, S., German, B., & Linder, N. (2006) · Mycoses · doi:10.1111/j.1439-0507.2005.01183.x · Cited by 46
Venditti, M., Bernardis, F. D., Micozzi, A., Pontieri, E., Chirletti, P., Cassone, A., & Martino, P. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.422 · Cited by 46
Treatment of experimental cryptococcal meningitis and disseminated candidiasis with SCH39304
Perfect, J. R., Wright, K. A., Hobbs, M. M., & Durack, D. T. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.10.1735 · Cited by 44
Penk, A., & Pittrow, L. B. (1999) · Mycoses · doi:10.1111/j.1439-0507.1999.tb00021.x · Cited by 43
Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis
Czerwiec, F. S., Bilsker, M., Kamerman, M. L., & Bisno, A. L. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90092-4 · Cited by 36
Bacak, V., Biočina, B., Starčević, B., Gertler, S., & Begovać, J. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.10.003 · Cited by 34
Fungal endocarditis in critically ill children
Aspesberro, F. P., Beghetti, M., Oberh�nsli, I., & Friedli, B. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051071 · Cited by 33
Martino, P., Meloni, G., & Cassone, A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-12-966_2 · Cited by 29
Witt, M. D., & Bayer, A. S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.12.2481 · Cited by 29
Long-Term Suppressive Therapy for Candida parapsilosis-Induced Prosthetic Valve Endocarditis
Baddour, L. M. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.8.773 · Cited by 27
Efficacy of Fluconazole in Prophylaxis and Treatment of Experimental Candida Endocarditis
Longman, L., Hibbert, S., & Martin, M. V. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.supplement_3.s294 · Cited by 27
Candida parapsilosis: An unusual organism causing prosthetic heart valve infective endocarditis
Darwazah, A. K., Berg, G., & Faris, B. (1999) · Journal of Infection · doi:10.1016/s0163-4453(99)90084-1 · Cited by 25
Medical Treatment of a Pacemaker Endocarditis due to Candida albicans and to Candida glabrata
Roger, P., Boissy, C., Gari-Toussaint, M., Foucher, R., Mondain, V., Vandenbos, F., Fichoux, Y. L., Michiels, J., & Dellamonica, P. (2000) · Journal of Infection · doi:10.1053/jinf.2000.0640 · Cited by 25
Yeaman, M. R., Cheng, D., Desai, B., Kupferwasser, L. I., Xiong, Y.-Q., Gank, K. D., Edwards, J. E., & Bayer, A. S. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3051-3056.2004 · Cited by 23 · cited 1×
“albicans endocarditis in vivo.(93) Louie and colleagues demonstrated in vitro that preexposure of C.”
BackgroundZahid, M. A., Klotz, S. A., & Hinthorn, D. R. (1994) · CHEST Journal · doi:10.1378/chest.105.5.1597 · Cited by 22
Candida lusitaniae: An Uncommon Cause of Prosthetic Valve Endocarditis
Wendt, B., Haglund, L., Razavi, A., & Rath, R. K. (1998) · Clinical Infectious Diseases · doi:10.1086/517126 · Cited by 21 · cited 1×
“Another of these patients was subsequently treated with valve replacement plus amphotericin B plus flucytosine followed by fluconazole; his blood cultures cleared on this regimen but he eventually died of refractory heart failure.(86) In a third patient, relapse at 3 months led to discontinuation of chronic suppressiv…”
BackgroundCandida endocarditis in a child with hyperimmunoglobulinemia E syndrome
Yates, A., Mehrotra, D., & Moffitt, J. E. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)80010-3 · Cited by 20
Successful Medical Treatment of Candida albicans in Mechanical Prosthetic Valve Endocarditis
Aaron, L., Therby, A., Viard, J., Lahoulou, R., & Dupont, B. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310008357 · Cited by 20
Treatment of native valve Candida endocarditis with fluconazole
Wells, C. J., Leech, G. J., Lever, A. M. L., & Wansbrough-Jones, M. H. (1995) · Journal of Infection · doi:10.1016/s0163-4453(95)80033-6 · Cited by 19
SAITO, Y., Takahashi, M., Akihiro, S. A. T. O., Katsuki, T., Ikeda, U., & Shimada, K. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.403 · Cited by 18
Lejko-Zupanc, T., & Koželj, M. (1997) · Journal of Infection · doi:10.1016/s0163-4453(97)91145-2 · Cited by 18
Westling, K., Thalme, A., & Julander, I. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021207-1 · Cited by 17
Karatza, A., Dimitriou, G., Marangos, M. N., Christofidou, M., Pavlou, V., Giannakopoulos, I. G., Darzentas, A., & Mantagos, S. P. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-007-0634-5 · Cited by 16 · cited 1×
“In 4 other patients, a fluconazole-containing regimen resulted in eventual clearance of candidemia with subsequent cure or improvement in all.(16,41,91) There were 14 episodes of relapse during treatment among 13 patients (Table 5).”
BackgroundDivekar, A. A., Rebekya, I. M., & Soni, R. N. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000126578.56127.c1 · Cited by 16
Witt, M. D., Imhoff, T., Li, C., & Bayer, A. S. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.9.2030 · Cited by 15
Thakur, R. K., SKELCY, K. M., KAHN, R. N., Cannon, L., & Cherukuri, R. (1994) · Critical Care Medicine · doi:10.1097/00003246-199404000-00031 · Cited by 15
Cancelas, J. A., López, J., Cabezudo, M.-E., Navas, E., Laraña, J. G., Mena, M. J., Diz, P., de Oteyza, J. P., Villalón, L. E. P., & Sánchez-Sousa, A. (1994) · PubMed · Cited by 15
Candida Endocarditis and Amphotericin B Intolerance: Potential Role for Fluconazole
Castiglia, M., Smego, R. A., & Sames, E. L. (1994) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-199407000-00004 · Cited by 14
Self-citationCandida parapsilosis endocarditis that emerged 2 years after abdominal surgery
Tonomo, K., Tsujino, T., Fujioka, Y., Nakao, S., Yao, H., Yasoshima, H., Kubota, A., Iwasaki, T., & Ohyanagi, M. (2004) · Heart and Vessels · doi:10.1007/s00380-003-0730-z · Cited by 14
Kaloterakis, A., Rizos, I. K., Goumas, G. S., Filiotou, A., Barbetseas, J. D., Papathanasiou, S., & TOUTOUZAS, P. K. (2003) · PubMed · Cited by 13
A case report of Candida parapsilosis endocarditis.
Inoue, Y., Yozu, R., Ueda, T., & KAWADA, S. (1998) · PubMed · Cited by 13
Candida parapsilosis endocarditis 8 months after transient candidemia
Khan, M. U., Ali, S., Baig, M., Rafiq, M. A., Vasavada, B. C., & Khan, I. A. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.12.067 · Cited by 12
Candida endocarditis in a premature infant
Mogyorósy, G., Soós, G., & Nagy, A. (2000) · Journal of Perinatal Medicine · doi:10.1515/jpm.2000.052 · Cited by 12
Chemlal, K., Saint-Julien, L., Joly, V., Farinotti, R., Séta, N., Yéni, P., & Carbon, C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.263 · Cited by 12
Native-valve endocarditis due to Candida parapsilosis
Kan, C. (2002) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1016/s1569-9293(02)00017-8 · Cited by 12
Daas, H., Abuhmaid, F., & Zervos, M. (2009) · Journal of Medical Case Reports · doi:10.1186/1752-1947-3-6598 · Cited by 11
Intracardiac fungal masses in high-risk neonates: clinical observations
Daftary, A. S., Patole, S., & Whitehall, J. (1999) · Acta Paediatrica · doi:10.1111/j.1651-2227.1999.tb00198.x · Cited by 11 · cited 2×
“Three patients clinically improved on fluconazole-containing antifungal therapy but died later in-hospital or during follow-up from thoracic wound hemorrhage(55) or complications of respiratory syncytial virus pneumonia(16) or renal failure.(16) For the patients with data given, follow-up ranged from 40 days to 8 year…”
BackgroundOcclusion of the common iliac artery secondary of fungal endocarditis: Report of a case
Veraldi, G. F., Guglielmi, A., Genna, M., Bertolini, P., Pasetto, E., Dusi, R., & Cordiano, C. (2000) · Surgery Today · doi:10.1007/s005950050062 · Cited by 10
Survival of candida sepsis in extracorporeal membrane oxygenation
Minette, M. S., & Ibsen, L. M. (2005) · Pediatric Critical Care Medicine · doi:10.1097/01.pcc.0000165563.61181.fb · Cited by 10
Salamon, S. A., Fuursted, K., Egeblad, H., Petersen, E., & Ott, P. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540601131968 · Cited by 10 · cited 1×
“In contrast, other authors have noted that amphotericin B monotherapy or amphotericin B combined with fluconazole significantly decreased fungal densities in cardiac vegetations in experimental Candida endocarditis compared to untreated controls or fluconazole monotherapy.(49,75) Louie et al(49,50) reported that ampho…”
ResultCandida parapsilosis tricuspid native valve endocarditis: 3-year follow-up after surgical treatment
Güllü, A. Ü., Akçar, M., Arnaz, A., & Kızılay, M. (2008) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1510/icvts.2007.173435 · Cited by 10
Nishida, T., Mayumi, H., Kawachi, Y., Tokunaga, S., Maruyama, Y., Nakashima, A., Yasui, H., & Tokunaga, K. (1994) · Surgery Today · doi:10.1007/bf01833735 · Cited by 9 · cited 1×
“Fluconazole monotherapy resulted in persistent candidemia in 4 patientsV2 were cured or improved on another regimen (1 containing fluconazole),(18,51) and 2 failed (1 of these died)(62,72)Vbut fluconazole cleared persistently positive blood cultures in a patient who had been taking miconazole unsuccessfully.(61) In 4…”
BackgroundJoly, V., & Carbon, C. (1998) · Clinical Infectious Diseases · doi:10.1086/514943 · Cited by 9
Excision of the tricuspid valve in a baby with Candida endocarditis
du Plessis, F. A., Helbing, W. A., & Bogers, A. J. J. C. (2007) · Cardiology in the Young · doi:10.1017/s104795110700056x · Cited by 9
Fluconazole in the treatment of Candida prosthetic valve endocarditis
Wallbridge, D. R., McCartney, A. C., & Richardson, M. D. (1993) · Mycoses · doi:10.1111/j.1439-0507.1993.tb00761.x · Cited by 8 · cited 1×
“One patient underwent, before antifungal therapy, surgery that consisted of ventriculoseptal defect closure; thrombectomy, and pulmonary artery exploration.(83)Another patient had an infected central venous catheter removed.”
BackgroundFluconazole therapy of candidal native valve endocarditis
Roupie, É., Darmon, J. Y., Brochard, L. J., Saada, M., Rekik, N., & Brun‐Buisson, C. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01968030 · Cited by 8
Candida prosthetic valve endocarditis. An autopsy review.
Otaki, M., & Kitamura, N. (1993) · PubMed · Cited by 8
Endocarditis caused by Candida parapsilosis.
Senba, M., Watanabe, K., Yoshida, K., Ochi, S., Matsumoto, K., Yano, K., & Itakura, H. (1992) · PubMed · Cited by 8
Ariffin, H., Ariffin, W., Tharam, S., Omar, A., Bruyne, J.-M. D., & Lin, H. P. (1999) · PubMed · Cited by 7
Noguchi, M., Takai, H., Eishi, K., & Atogami, S. (2004) · The Japanese Journal of Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-004-0052-9 · Cited by 7
Candida Endocarditis in an Infant
Hartyánszky, I. L., Pinter, M., Kádár, K., Oprea, V., Krause, I., & Lozsádi, K. (1997) · Pediatric Cardiology · doi:10.1007/s002469900225 · Cited by 7
Bayer, A. S., Witt, M. D., Kim, E.-S., & Ghannoum, M. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.494 · Cited by 7
[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
Castillo, M. D., Wainsztein, N., Klein, F., Manganello, S., & Orellana, N. (2004) · PubMed · Cited by 6
Jones, J. M., Sarsam, M., Clarke, M., & Hedderwick, S. A. (2002) · Journal of Infection · doi:10.1053/jinf.2001.0929 · Cited by 6
[Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
Roel, J. E., Gamba, A., Curone, M., Pescio, A., Bruno, C., & Finquelievich, J. L. (1998) · PubMed · Cited by 6
Hernandez, J. A., Gonzalez-Moreno, M., Llibre, J. M., Aloy Duch, A., & Casan, J. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.6.1062 · Cited by 6 · cited 2×
“There were 12 treatment failures involving 11 regimens containing fluconazole (7 instances of monotherapy and 4 combinations); 1 person failed on amphotericin B but clinically improved on fluconazole.(33) Overall, 49 of 64 (77%) patients were cured (n = 44) or improved (clinical T mycologic improvement) (n = 5), 4 rel…”
Background[Value of fluconazole in the treatment of systemic yeast infection].
Bernard, E., Carles, M., Gari-Toussaint, M., Jp, F., & Dellamonica, P. (1989) · PubMed · Cited by 6
Candida parapsilosis endocarditis in aged patient
Marti, J. L. G. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2008.07.015 · Cited by 5 · cited 1×
“Voriconazole, but not posaconazole, has been used in the treatment of Candida endocarditis, but clinical experience is extremely limited.(48,52,53,67) While fluconazole is commonly used for chronic suppression in patients with Candida endocarditis, to our knowledge its precise role in the management of this infection…”
[Fungal endocarditis found at onset of lower limb acute aortic occlusion; report of a case].
Hariya, A., Naruse, Y., Kobayashi, T., Endo, M., Ikeda, Y., Yoshii, T., Momomura, S., Ishiwata, S., & Maehara, A. (2005) · PubMed · Cited by 5
Endocardite à Candida albicans sur cerclage de l’artère pulmonaire
Talvard, M., Paranon, S., Dulac, Y., Mansir, T., Kreitmann, B., & Acar, P. (2009) · Archives de Pédiatrie · doi:10.1016/j.arcped.2009.05.005 · Cited by 4
Kindel, M., Sternfeldt, R., & Spiller, P. (2002) · Zeitschrift für Kardiologie · doi:10.1007/s00392-002-0836-9 · Cited by 3
Postoperative endocarditis due to Candida tropicalis.
Mathew, R., Ms, R., & Mr, R. (1999) · PubMed · Cited by 3
Piñar, D., Reus, S., Pérez-Berbel, P., & Quiles, J. A. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2009.02.009 · Cited by 2
A Case of Candida albicans Endocarditis with Impaired Lung Function
Yamamoto, W., Takashi, I. N. O., Sakurabayashi, I., Hirohumi, I. D. E., & Yaginuma, T. (1992) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi1970.66.536 · Cited by 2
[Retrospective analysis of 15 patients with fungal septicaemia].
Deng, G.-Y., & Wang, A. (2001) · PubMed · Cited by 2
[A case of endocarditis caused by Candida glabrata].
Kurata, H., Ozaki, T., Kase, M., Nakayama, H., Nakamura, N., Ichikawa, Y., Kondo, J., & Matsumoto, A. (1993) · PubMed · Cited by 1
Research works printed but not linked: 2
- Pinar, 2010, Conservative management with new antifungals in a case of Candida prosthetic valve endocarditis., Enferm Infecc Microbiol Clin, 28, 66
- Yap, 1999, Successful treatment of Candida albicans endocarditits in a child with leukemia: a case report and review of the literature., Singapore Med J, 40, 533
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
“predominate, the latter resulting in BCNIE.(199,200) Mortality is very high (.”
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
“high rate of relapse and mortality [354].”
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“After completion of this initial therapy, long-term (lifelong) suppressive therapy with an oral azole is reasonable.(243,244,246) Suppressive therapy has been used in 2 populations.”
Background2023 ESC Guidelines for the management of endocarditis
Delgado, V., Ajmone Marsan, N., de Waha, S., Bonaros, N., Brida, M., Burri, H., Caselli, S., Doenst, T., Ederhy, S., Erba, P. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad193 · Cited by 1,754
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Metadata
- Authors
- Smego, R. A., & Ahmad, H.
- Affiliations
- Geisinger College of Health Sciences (US)
- Venue
- Medicine
- Published
- 2011-07
- Volume
- 90
- Issue
- 4
- Pages
- 237-249
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2334211593
- Semantic Scholar
- 63dc656ff2b21f91623d05890a321decd1decdb2
- Cited by
- 56
- References
- 94
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 1 · 2012: 3
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- Candida endocarditis, fluconazole, antifungal therapy, combination antifungal therapy, valve replacement, prosthetic valve endocarditis, native valve endocarditis, amphotericin B, 5-fluorocytosine, treatment outcomes
- MeSH terms
- Adult, Aged, Aged, 80 and over, Antifungal Agents, Candida albicans, Candidiasis, Dose-Response Relationship, Drug, Drug Administration Schedule, Endocarditis, Female, Humans, Male, Middle Aged, Prognosis, Recurrence, Severity of Illness Index, United States, Fluconazole, Survival Rate, Treatment Outcome, Risk Assessment, Candidemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.